Post‑operative Anticoagulation and Follow‑up after Mitral Valve Repair with an Annuloplasty Ring

Anticoagulation Strategy

• All patients receive oral anticoagulation for the first 3 months after mitral valve repair with a prosthetic annuloplasty ring. [​1, 2, 3, 4] – Evidence: consensus recommendation.
• Start intravenous unfractionated heparin immediately after surgery, targeting an aPTT of 1.5–2.0 × control until a therapeutic INR is reached with oral anticoagulation. [​2, 3, 4] – Evidence: expert opinion.
• Intravenous heparin is considered safer than subcutaneous low‑molecular‑weight heparin (LMWH) or subcutaneous unfractionated heparin, although no randomized trials exist. [​2, 3, 4] – Evidence: observational.
• If LMWH is used, antifactor‑Xa activity must be monitored, especially in patients with renal impairment or obesity where dosing is challenging. [​2, 3, 4] – Evidence: expert guidance.

Oral Anticoagulation Duration

• Vitamin‑K antagonists (warfarin) are required for at least 3 months in every patient with a mitral valve repair that includes a prosthetic annuloplasty ring. [​1, 2, 3, 4] – Evidence: consensus.
• Aspirin alone is sometimes used as an alternative, but no randomized studies support its safety in this setting. [​1, 2, 3, 4] – Evidence: lack of RCT data.

Long‑Term Anticoagulation

• Lifelong anticoagulation is indicated when any of the following are present: atrial fibrillation, heart failure, or left‑ventricular ejection fraction < 30 %. [​1, 2, 3, 4] – Evidence: expert consensus.
• Patients without these indications should undergo close clinical follow‑up to detect new atrial fibrillation and structural degeneration of the repair. [​5, 1, 2, 3, 4] – Evidence: consensus monitoring.

Cardiac Rehabilitation and Exercise

• A multidisciplinary cardiac rehabilitation program should be offered to all post‑repair patients, particularly those with a complicated postoperative course or heart‑failure features. [​2, 3, 4] – Evidence: guideline‑based recommendation.
• Patients with successful repair and preserved left‑ventricular function are suitable candidates for structured exercise training. [​2, 3, 4] – Evidence: expert opinion.
• A submaximal exercise test performed ≈ 2 weeks after surgery is recommended to individualize exercise prescriptions. [​2, 3, 4] – Evidence: consensus.

Echocardiographic Surveillance

• Obtain a baseline transthoracic echocardiogram after surgery and again at the end of rehabilitation to serve as reference for future studies. [​2, 3, 4] – Evidence: guideline practice.
• Serial echocardiography (transthoracic or transesophageal) is essential for early detection of recurrent mitral regurgitation, structural ring degeneration, and new‑onset atrial fibrillation. [​1, 2, 3, 4] – Evidence: consensus.

Endocarditis Prophylaxis and Management

• Lifelong antibiotic prophylaxis for dental, endoscopic, and surgical procedures is required in patients with annuloplasty rings. [​5, 6] – Evidence: guideline recommendation.
• The risk of prosthetic‑valve endocarditis peaks during the first 3–6 months after implantation but remains relatively constant thereafter. [​5, 6] – Evidence: epidemiologic data.
• Maintain vigilance for signs of prosthetic‑valve endocarditis throughout follow‑up; the overall risk is lower than with full prosthetic valves. [​5, 6] – Evidence: expert consensus.
• If endocarditis is suspected, refer immediately to a cardiac centre capable of valve surgery. [​5, 6] – Evidence: best‑practice recommendation.
• Obtain multiple blood cultures before initiating antibiotics. [​5, 6] – Evidence: standard microbiologic protocol.
• Transesophageal echocardiography is essential for detecting vegetations, paraprosthetic abscesses, or new leaks. [​5, 6] – Evidence: diagnostic guideline.
• Serial transesophageal studies by an experienced operator are advised because early changes may be subtle. [​5, 6] – Evidence: expert recommendation.

Patient Education

• Educate patients on anticoagulation management, including drug‑interaction risks. [​4] – Evidence: consensus.
• Teach self‑management of anticoagulation when appropriate. [​3] – Evidence: expert guidance.
• Instruct patients to recognize bleeding, embolic events, and symptoms of endocarditis. [​6] – Evidence: safety education.
• Promote a healthy lifestyle (diet, activity, smoking cessation). [​3] – Evidence: preventive counseling.

Management of Anticoagulation Complications

• An INR of 6.0 mandates reversal of anticoagulation. [​1, 3, 4] – Evidence: safety protocol.
• In non‑bleeding prosthetic‑valve patients, avoid intravenous vitamin K because rapid INR reduction can precipitate valve thrombosis. [​1, 3, 4] – Evidence: expert recommendation.
• Management steps: admit to hospital, stop oral anticoagulant, and allow INR to fall gradually. [​1, 3, 4] – Evidence: clinical pathway.
• If INR exceeds 10.0, consider administration of fresh‑frozen plasma. [​1, 3, 4] – Evidence: guideline‑based intervention.

Prevention of Thromboembolic Events

• Address modifiable risk factors: atrial fibrillation, hypertension, hypercholesterolemia, diabetes, smoking, chronic infection, and pro‑thrombotic hematologic abnormalities. [​6, 5] – Evidence: preventive strategy.
• Optimize anticoagulation control, preferably using patient self‑management when feasible. [​3] – Evidence: quality‑of‑care recommendation.
• Antiplatelet agents should not be prescribed routinely; they are reserved for specific indications (e.g., arterial disease) and used cautiously because of increased bleeding risk. [​5] – Evidence: risk‑benefit guidance.

Anticoagulation Target INR After Mitral Annuloplasty

INR Goal Recommendations

Guidelines for Dental Care After Mitral Valve Repair

Endocarditis Prophylaxis

• Lifelong antibiotic prophylaxis is required before any dental procedure that manipulates gingival tissue or the periapical region of teeth, including routine cleanings, for patients who have undergone mitral valve repair with a prosthetic annuloplasty ring. 8
• The presence of a prosthetic annuloplasty ring classifies the repair as prosthetic material; therefore, valve repair does not eliminate the need for endocarditis prophylaxis. 8

Recommended Antibiotic Regimen

These regimens are endorsed for all dental interventions in this patient population. 8

Anticoagulation Management (First 3 Months Post‑Surgery)

• All patients receive oral warfarin for the first three months after mitral valve repair with an annuloplasty ring, with a target INR of 2.0–3.0. 9

Transition to Antiplatelet Therapy (Beyond 3 Months)

• If, after three months, the patient remains in sinus rhythm and has no atrial fibrillation, heart failure, or left‑ventricular ejection fraction < 30 %, they may be switched from warfarin to low‑dose aspirin (75–100 mg daily). 9

Post‑Operative Assessment Prior to Dental Care

• Completion of a baseline post‑operative echocardiogram is recommended before scheduling the first dental cleaning, to confirm valve function and stability. 9